Correspondence 0001214659-25-005436 from Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc.
Date: April 4, 2025 · CIK: 0001677077 · Accession: 0001214659-25-005436
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285788
Letter
Re: Alzamend Neuro, Inc. Registration Statement on Form S-1/A (File No. 333-285788)
ALZAMEND NEURO, INC. 3480 Peachtree Road NE
Second Floor, Suite 103 Atlanta, GA 30326
April 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention: Jessica Dickerson and Joshua Gorsky Division of Corporation Finance
Ladies and Gentlemen:
Alzamend Neuro, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:00 p.m., Eastern time, on Tuesday, April 8, 2025, or as soon as possible thereafter.
We request that we be notified of such effectiveness by a telephone call or e-mail to the undersigned at (646) 650-5044 or henry@alzamend.com.
Very truly yours,
ALZAMEND NEURO, INC.
Show Raw Text
CORRESP 1 filename1.htm ALZAMEND NEURO, INC. 3480 Peachtree Road NE Second Floor, Suite 103 Atlanta, GA 30326 April 4, 2025 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jessica Dickerson and Joshua Gorsky Division of Corporation Finance Re: Alzamend Neuro, Inc. Registration Statement on Form S-1/A (File No. 333-285788) Ladies and Gentlemen: Alzamend Neuro, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:00 p.m., Eastern time, on Tuesday, April 8, 2025, or as soon as possible thereafter. We request that we be notified of such effectiveness by a telephone call or e-mail to the undersigned at (646) 650-5044 or henry@alzamend.com. Very truly yours, ALZAMEND NEURO, INC. By: /s/ Henry Nisser Henry Nisser Executive Vice President and General Counsel cc: Kenneth Schlesinger, Esq. Spencer G. Feldman, Esq.